Lipitor, Atorvastatin Newswire (Page 9)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 9)

Results 161 - 180 of 1,076 in Lipitor, Atorvastatin (generic)

  1. Pfizer's Videos Argue for AstraZeneca DealRead the original story w/Photo

    May 11, 2014 | TheStreet.com

    He said Pfizer had expanded its research in Cambridge, Mass., and envisions pursuing a similar strategy for Britain's Cambridge, north of London, where many scientists work.

    Comment?

  2. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Release of Study...Read the original story w/Photo

    Jun 3, 2014 | PRWeb

    The Firm is evaluating Lipitor lawsuits on behalf of patients who allegedly developed Type 2 diabetes due to their use of the statin medication.

    Comment?

  3. Pine bark substance could be potent melanoma drugRead the original story w/Photo

    May 20, 2014 | Science Daily

    A substance that comes from pine bark is a potential source for a new treatment of melanoma, according to researchers.

    Comment?

  4. Elucidating Biosimilars CharacterizationRead the original story

    Oct 2, 2013 | Pharmaceutical Technology

    The global market for biosimilar drugs has been forecasted to be $2.445 billion in 2013 according to a report by the British market-research firm, Visiongain .

    Comment?

  5. Overcoming cancer to run the Aramco Half Marathon: an interview with Brandy VargasRead the original story w/Photo

    Jan 23, 2010 | Examiner.com

    Houstonian , Brandy Vargas , ran her first half marathon on Sunday, only training for the EP5K .

    Comment?

  6. Pfizer Discount Keeps Brand-Name Lipitor CheapRead the original story

    Jun 2, 2014 | Manufacturing.net

    Patients who prefer brand-name cholesterol drug Lipitor to an inexpensive generic version will find it more affordable, thanks to a new discount offer from drug maker Pfizer Inc. They'll be able to get Lipitor, the highest-selling prescription medicine in history, for $30 or less per month- not much more than a generic - under Pfizer's Lipitor ... (more)

    Comment?

  7. FDA Approves Merck's NOXAFIL (posaconazole) Delayed-Release TabletsRead the original story

    Nov 26, 2013 | Pharma. & Medical Packaging News

    Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL 100 mg delayed-release tablets.

    Comment?

  8. 'Got statins? Expect weight gainRead the original story w/Photo

    May 31, 2014 | Examiner.com

    It seems that people who take statins are letting down their guard. Erroneously reasoning that they are protected from the health consequences of eating more fat and calories, statin users delve into more bad foods.

    Comment?

  9. Is This Science or Censorship?Read the original story

    May 30, 2014 | Psychology Today

    There are two parts to this story. The first involves a scientific debate about new guidelines for prescribing cholesterol-lowering drugs .

    Comment?

  10. Cholesterol-lowering statins linked to higher diabetes risk: studyRead the original story

    May 29, 2014 | CTV

    Patients who take strong cholesterol-lowering drugs called statins may be at greater risk of developing diabetes, a Canadian study has found.

    Comment?

  11. Therapeutics Initiative warns of statin side effectsRead the original story

    May 29, 2014 | University of British Columbia

    A report from the Therapeutics Initiative at the University of British Columbia urges physicians to exercise greater vigilance when prescribing statins to prevent heart disease and stroke because of the potential for harmful side effects.

    Comment?

  12. Why Pfizer Will Never Be the Same AgainRead the original story

    May 28, 2014 | The Motley Fool

    After AstraZeneca rebuffed Pfizer's "final offer" last week, it automatically triggered a minimum three month "cooling off period" under U.K. bid rules.

    Comment?

  13. Pfizer walks away from AstraZeneca fightRead the original story w/Photo

    May 27, 2014 | Chicago Tribune

    Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds on Monday as a deadline approached without a last-minute change of heart by the British drugmaker.

    Comment?

  14. Pfizer walks away from $138b dealRead the original story

    May 27, 2014 | Stuff.co.nz

    Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion on Monday as a deadline approached without a last-minute change of heart by the British drugmaker.

    Comment?

  15. Lipitor Diabetes Claimants Continue to Join Federal Litigation, More...Read the original story

    May 26, 2014 | PRWeb

    The Firm is currently offering free and confidential Lipitor lawsuit evaluations to individuals who may have developed Type 2 diabetes after taking the cholesterol-lowering statin.

    Comment?

  16. Pfizer abandons AstraZeneca bidRead the original story w/Photo

    May 26, 2014 | RTE.ie

    British takeover rules mean it will be at least three months before any fresh talks can take place between the companies Pfizer has said it had abandoned its current attempt to buy AstraZeneca for nearly 70bn as a deadline approached without a last-minute change of heart by the British drugmaker.

    Comment?

  17. Pfizer drops pursuit of AstraZenecaRead the original story w/Photo

    May 26, 2014 | Courier News

    Pfizer says it does not intend to make a new offer after the British drugmaker's rejection of its $119 billion bid last week.

    Comment?

  18. Pfizer walks away from AstraZeneca takeover attemptRead the original story w/Photo

    May 26, 2014 | The Baltimore Sun

    Pfizer said on Monday it had abandoned its current attempt to buy AstraZeneca for nearly $118 billion - a deal watched warily by Maryland officials - as a deadline approached without a last-minute change of heart by the British drugmaker.

    Comment?

  19. Pfizer halts AstraZeneca takeover attemptRead the original story w/Photo

    May 26, 2014 | The Baltimore Sun

    Pfizer said on Monday it had abandoned its current attempt to buy AstraZeneca for nearly $118 billion - a deal watched warily by Maryland officials - as a deadline approached without a last-minute change of heart by the British drugmaker.

    Comment?

  20. Heart disease: Canadian treatment using vegetables over drugsRead the original story

    May 26, 2014 | Canadian Content

    "What we're told by pharmaceutical companies is that only 10 per cent of the cholesterol in our bloodstream is what we consume, and the rest is made by our liver.

    Comment?